Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

For an Investigator-led Hair Study Comparing Between Healthy and Hair Loss Volunteers

This study is to evaluate differences in the gut and follicle/scalp microbiome signature in AGA compared to a non-AGA population. Also, to investigate differences in inflammation and other biomarkers in AGA compared to non-AGA population at baseline and after a successful treatment

Participants needed: 66
Trial details
Age: 21-45Biological sex: MaleType: ObservationalSponsor: National Skin CentreUpdated: Jul 21, 2026
Eligibility criteria

Male volunteer from 21 to 45 years old [+10]

Volunteer with severe gastro-intestinal symptoms (including gluten and lactose i... [+33]

Status: Not yet recruiting

Non-interventional Translational Study in Mild, Moderate and Severe Acne Patients

This study aims to uncover the specific immunopathology, microbiome and pathophysiology of acne vulgaris in people living in a tropical climate such as Singapore. This is a largely unexplored population in terms of acne pathogenesis, and will lead to population-specific interventions for the management of acne vulgaris.

Participants needed: 200
Trial details
Age: 18-25Biological sex: AllType: ObservationalSponsor: National Skin CentreUpdated: Feb 17, 2026Duration: 1 Day
Eligibility criteria

Mild facial acne vulgaris defined as Investigator's Global Assessment (IGA) of 2... [+3]

Status: Recruiting

Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars

This randomized, double-blind controlled study aims to compare the effect on appearance of post- surgical scars between daily application of siSPARC microneedle patch versus siSPARC + siLR4A microneedle patches. These are patches comprising short microneedles embedded with hydrolysed RNA (siRNAs).

Participants needed: 50
Trial details
Phase: Phase 2Age: 21-75Biological sex: AllType: InterventionalSponsor: National Skin CentreUpdated: Jun 24, 2024Locations: 1
Eligibility criteria

Adult [+4]

Pregnant or lactating participant [+4]